CDC/ACIP [to 18 November 2017]

CDC/ACIP [to 18 November 2017]
Wednesday, November 15, 2017

CDC Encourages Safe Antibiotic Prescribing and Use – Press Release
November 13, 2017, kicked off U.S. Antibiotic Awareness Week and World Antibiotic Awareness Week. The Centers for Disease Control and Prevention (CDC) recognizes this week with an updated educational effort, Be Antibiotics Aware: Smart Use, Best Care, to support the nation’s efforts to combat antibiotic resistance through improved use of these life-saving medications…

MMWR News Synopsis for November 16, 2017
Global Routine Vaccination Coverage, 2016
In recent years, vaccination coverage rates have remained the same. This suggests the need to improve access to and completion of vaccinations for hard-to-reach populations in order to reduce global morbidity and mortality from vaccine-preventable diseases.
Substantial progress in global routine vaccination coverage has been made in the past 40 years since the establishment of the World Health Organization (WHO) Expanded Program on Immunization (EPI). In 2016, the global vaccination coverage rate with vaccines to prevent tuberculosis, diphtheria, tetanus, pertussis, polio, and measles was ≥85 percent. However, 33 percent of countries still are not meeting the target requirements needed to reach and sustain high vaccination coverage. Targeted strategies are needed to improve access to vaccination and to increase the number of children who are fully protected from vaccine-preventable diseases.

Rubella and Congenital Rubella Syndrome Control and Elimination — Global Progress, 2000–2016
The accelerated introduction of rubella-containing vaccine (RCV) into national immunization schedules is a significant step toward. rubella elimination. For regions to achieve rubella elimination, as has been achieved in the Americas, a strong commitment is required in all countries to introduce rubella-containing vaccine and increase the quality of rubella routine and campaign immunization activities. Countries and international partners should take advantage of opportunities provided by existing measles-elimination activities.
Rubella is the leading vaccine-preventable cause of birth defects in the world. Rubella during pregnancy can cause miscarriage, fetal death, stillbirth, and congenital malformations known as congenital rubella syndrome (CRS). During 2000-2016, 53 countries introduced RCV into their national immunization schedules. By the end of 2016, 152 (78 percent) of 194 countries were using rubella vaccine. Reported rubella cases declined 97 percent, from 670,894 cases in 102 countries in 2000 to 22,361 cases in 165 countries in 2016. The WHO Americas region achieved rubella and CRS elimination in 2015, and 33 of 53 countries in the European region have eliminated endemic rubella and CRS. The Western Pacific Region also has a rubella elimination goal (no countries verified).